Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer. — المؤلف: Ricciuti, Biagio — Journal for immunotherapy of cancer 20200616

المؤلف
Ricciuti, Biagio
النشر
Journal for immunotherapy of cancer 20200616
الوصف
87 p.
الموضوعات
Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Agents, Immunological؛ B7-H1 Antigen؛ Biomarkers, Tumor؛ CTLA-4 Antigen؛ Carcinoma, Non-Small-Cell Lung